The Oatmeal Bite

The Oatmeal Bite

62,000 Preventable Deaths and the Interval No One Is Measuring

Two studies confirm that delay between scan and surgery costs lives. Only 24.5% of eligible adults are screened. The pathway problem runs deeper than the 92% survival figure suggests.

Jonathan Govette, CEO/Oatmeal's avatar
Jonathan Govette, CEO/Oatmeal
Nov 02, 2026
∙ Paid

Lung cancer survival has a headline figure that gets repeated in board presentations, grant applications, and hospital marketing materials: 92% ten-year survival for stage I disease found through screening. The number comes from the International Early Lung Cancer Action Program, published in the New England Journal of Medicine in 2006. It is real, it is remarkable, and it belongs to a specific group of patients who were diagnosed and operated on within one month.

Most programs repeat the 92% and stop there. The productive question is what it takes to replicate it, because the answer involves a set of intervals most health systems are not measuring and a patient population most programs are not reaching.

User's avatar

Continue reading this post for free, courtesy of Jonathan Govette, CEO/Oatmeal.

Or purchase a paid subscription.
© 2026 Jonathan Govette · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.